BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23352598)

  • 21. Interventricular differences in myofilament function in experimental congestive heart failure.
    Belin RJ; Sumandea MP; Sievert GA; Harvey LA; Geenen DL; Solaro RJ; de Tombe PP
    Pflugers Arch; 2011 Dec; 462(6):795-809. PubMed ID: 21927813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.
    Rice R; Guinto P; Dowell-Martino C; He H; Hoyer K; Krenz M; Robbins J; Ingwall JS; Tardiff JC
    J Mol Cell Cardiol; 2010 May; 48(5):979-88. PubMed ID: 20004663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
    Lehman SJ; Tal-Grinspan L; Lynn ML; Strom J; Benitez GE; Anderson ME; Tardiff JC
    Circulation; 2019 Mar; 139(12):1517-1529. PubMed ID: 30586744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-translational modifications of myofilament proteins involved in length-dependent prolongation of relaxation in rabbit right ventricular myocardium.
    Monasky MM; Taglieri DM; Jacobson AK; Haizlip KM; Solaro RJ; Janssen PM
    Arch Biochem Biophys; 2013 Jul; 535(1):22-9. PubMed ID: 23085150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
    Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
    Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I.
    Zhou Z; Rieck D; Li KL; Ouyang Y; Dong WJ
    Arch Biochem Biophys; 2013 Jul; 535(1):56-67. PubMed ID: 23246786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM.
    Piroddi N; Witjas-Paalberends ER; Ferrara C; Ferrantini C; Vitale G; Scellini B; Wijnker PJM; Sequiera V; Dooijes D; Dos Remedios C; Schlossarek S; Leung MC; Messer A; Ward DG; Biggeri A; Tesi C; Carrier L; Redwood CS; Marston SB; van der Velden J; Poggesi C
    J Gen Physiol; 2019 Jan; 151(1):18-29. PubMed ID: 30578328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
    Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by Genetic Research, Toward Future Therapy.
    Hayashi T
    Keio J Med; 2020 Dec; 69(4):77-87. PubMed ID: 32224552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
    Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
    J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional impact of troponin C-mediated Ca
    Gonzalez-Martinez D; Johnston JR; Landim-Vieira M; Ma W; Antipova O; Awan O; Irving TC; Bryant Chase P; Pinto JR
    J Mol Cell Cardiol; 2018 Oct; 123():26-37. PubMed ID: 30138628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS; Moolman-Smook JC; Watkins H
    Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
    Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
    Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
    Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
    J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
    Bayliss CR; Jacques AM; Leung MC; Ward DG; Redwood CS; Gallon CE; Copeland O; McKenna WJ; Dos Remedios C; Marston SB; Messer AE
    Cardiovasc Res; 2013 Mar; 97(3):500-8. PubMed ID: 23097574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
    Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M
    J Phys Chem B; 2016 Aug; 120(33):8238-53. PubMed ID: 27150586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
    Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
    Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.